🇺🇸 FDA
Pipeline program

SerpinPC

AP-0103

Phase 2 small_molecule terminated

Quick answer

SerpinPC for Hemophilia B with Inhibitor is a Phase 2 program (small_molecule) at Centessa Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).

Program details

Company
Centessa Pharmaceuticals plc
Indication
Hemophilia B with Inhibitor
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials